British drug-cost watchdog recommends use of AbbVie's ovarian cancer therapy

June 4 (Reuters) - The UK cost-effectiveness watchdog on Thursday recommended AbbVie's "guided missile" cancer therapy, ...
Chicago Tribune

FDA calls out AbbVie over ‘misleading’ commercial featuring Serena Williams

The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that a migraine medication commercial featuring Serena Williams is “misleading.
FiercePharma

AbbVie goes all-in on Vuity's unique selling point in first ad campaign for the eye drop

AbbVie is airing its first TV commercial for its eye drop Vuity four months after its FDA approval and the focus is—well, focus. The eye drop can help improve eyesight and eliminate the need for ...
Fierce Pharma

With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset

As AbbVie continues to capitalize on its ImmunoGen deal, the growth of commercial antibody-drug conjugate (ADC) Elahere, another of the acquired company’s clinical assets has crossed the FDA finish ...
JD Supra

ABBVIE V. AMGEN: Amgen Agrees To Comply With The BPCIA Notice Of Commercial Marketing Requirements

Today, in the AbbVie v. Amgen adalumimab case, Judge Robinson entered a stipulated order that dismissed Count XI of AbbVie’s Complaint. With its Count XI, AbbVie sought an order compelling Amgen to ...